AR057623A1 - Materiales y metodos para el tratamiento de las infecciones virales - Google Patents
Materiales y metodos para el tratamiento de las infecciones viralesInfo
- Publication number
- AR057623A1 AR057623A1 ARP060105117A ARP060105117A AR057623A1 AR 057623 A1 AR057623 A1 AR 057623A1 AR P060105117 A ARP060105117 A AR P060105117A AR P060105117 A ARP060105117 A AR P060105117A AR 057623 A1 AR057623 A1 AR 057623A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- influenza
- materials
- methods
- viral infections
- Prior art date
Links
- 208000036142 Viral infection Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 241000712461 unidentified influenza virus Species 0.000 abstract 3
- -1 cysteamine compound Chemical class 0.000 abstract 2
- 229960003151 mercaptamine Drugs 0.000 abstract 2
- 230000009385 viral infection Effects 0.000 abstract 2
- 241000713297 Influenza C virus Species 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 208000037797 influenza A Diseases 0.000 abstract 1
- 208000037798 influenza B Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Materiales y métodos para el tratamiento de diversos trastornos de salud, incluyendo la prevencion y/o tratamiento de una infeccion viral. En una realizacion preferida, se administra un compuesto de cisteamina a un sujeto para tratar una infeccion por el virus de la influenza. Más preferentemente, se administra un compuesto de cisteamina a un sujeto para tratar infecciones por los virus influenza A, influenza B, influenza C, incluyendo los subtipos de virus influenza aviar (tales como el virus influenza aviar H5N1).
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74058405P | 2005-11-28 | 2005-11-28 | |
US81077306P | 2006-06-02 | 2006-06-02 | |
US81888506P | 2006-07-06 | 2006-07-06 | |
US84702006P | 2006-09-25 | 2006-09-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR057623A1 true AR057623A1 (es) | 2007-12-05 |
Family
ID=37769370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060105117A AR057623A1 (es) | 2005-11-28 | 2006-11-22 | Materiales y metodos para el tratamiento de las infecciones virales |
Country Status (21)
Country | Link |
---|---|
US (2) | US8415398B2 (es) |
EP (1) | EP1954258B8 (es) |
JP (1) | JP5138603B2 (es) |
KR (1) | KR101440629B1 (es) |
CN (1) | CN102038667A (es) |
AP (1) | AP2877A (es) |
AR (1) | AR057623A1 (es) |
AU (1) | AU2006318355B2 (es) |
BR (1) | BRPI0619377A2 (es) |
CA (1) | CA2631241C (es) |
DK (1) | DK1954258T3 (es) |
ES (1) | ES2392976T3 (es) |
HK (1) | HK1123726A1 (es) |
IL (1) | IL191705A (es) |
MX (1) | MX2008006851A (es) |
MY (1) | MY141003A (es) |
NZ (1) | NZ568464A (es) |
PL (1) | PL1954258T3 (es) |
PT (1) | PT1954258E (es) |
TW (1) | TWI401079B (es) |
WO (1) | WO2007062272A1 (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1706104A2 (en) * | 2004-01-13 | 2006-10-04 | Omega Bio-Pharma (I.P.2) Limited | Methods for treating stress and affecting biological immune systems using a cysteamine compound |
AR057623A1 (es) * | 2005-11-28 | 2007-12-05 | Omega Bio Pharma H K Ltd | Materiales y metodos para el tratamiento de las infecciones virales |
HUE049307T2 (hu) | 2006-01-27 | 2020-09-28 | Univ California | Bélben oldódó bevonattal ellátott ciszteamin-bitartrát és cisztamin |
WO2009023356A2 (en) * | 2007-05-25 | 2009-02-19 | Omega-Biopharma (H.K.) Limited | Materials and methods for treating influenza infections |
WO2009129305A2 (en) | 2008-04-15 | 2009-10-22 | Tsrl, Inc. | Prodrugs of neuraminidase inhibitors |
GB0905451D0 (en) * | 2009-03-31 | 2009-05-13 | Novabiotics Ltd | Biofilms |
WO2010138419A2 (en) * | 2009-05-23 | 2010-12-02 | Obio Pharmaceutical (H.K.) Ltd. | Materials and methods for treating viral infections |
WO2011094693A1 (en) * | 2010-02-01 | 2011-08-04 | Mount Sinai School Of Medicine | Interferon-inducing compounds and uses thereof |
EP2558097B1 (en) * | 2010-04-15 | 2017-10-25 | Biota Scientific Management Pty Ltd | Vapendavir for the alleviation of symptoms of asthma in a subject having a HRV infection |
GB201021186D0 (en) | 2010-12-14 | 2011-01-26 | Novabiotics Ltd | Composition |
EA201490836A1 (ru) | 2011-10-21 | 2014-11-28 | Эббви Инк. | Комбинационное лечение (например, с abt-072 или abt-333) с помощью daa для применения при лечении hcv |
US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
GB2515941A (en) | 2011-10-21 | 2015-01-07 | Abbvie Inc | Methods for treating HCV comprising at least two direct acting antiviral agent, ribavirin but not interferon |
US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
TWI649100B (zh) | 2013-06-17 | 2019-02-01 | 地平線罕見醫學製藥有限責任公司 | 延遲釋放型半胱胺珠粒調配物,以及其製備及使用方法 |
CA2923075C (en) | 2013-09-12 | 2022-07-26 | Alios Biopharma, Inc. | Aza-pyridone compounds and uses thereof |
EA036776B1 (ru) | 2015-03-11 | 2020-12-21 | Янссен Байофарма, Инк. | Соединения азапиридона и способы их применения |
US10143665B2 (en) | 2015-11-17 | 2018-12-04 | Horizon Orphan Llc | Methods for storing cysteamine formulations and related methods of treatment |
MX2018011278A (es) | 2016-03-17 | 2019-07-08 | Thiogenesis Therapeutics Inc | Composiciones para la liberacion controlada de cisteamina y el tratamiento sistemico de trastornos sensibles a la cisteamina. |
CN109689063A (zh) | 2016-04-28 | 2019-04-26 | 埃默里大学 | 含有炔烃的核苷酸和核苷治疗组合物及其相关用途 |
GB201609940D0 (en) | 2016-06-07 | 2016-07-20 | Novabiotics Ltd | Microparticles |
US10905660B2 (en) * | 2016-06-07 | 2021-02-02 | Novabiotics Limited | Microparticles |
AU2017376922B2 (en) | 2016-12-15 | 2022-12-01 | Société des Produits Nestlé S.A. | Compositions and methods that modulate phosphorus or enzymes in a companion animal |
CN111683684A (zh) | 2017-09-20 | 2020-09-18 | 硫创治疗公司 | 用于治疗半胱胺敏感性病症的方法 |
US20230218571A1 (en) * | 2020-04-01 | 2023-07-13 | Thiogenesis Therapeutics, Inc. | Cysteamine precursor compounds for the treatment of betacoronavirus infections |
WO2021231570A1 (en) * | 2020-05-13 | 2021-11-18 | The Regents Of The University Of Michigan | Cysteamine for the treatment of sars-cov-2 infection |
IL298267A (en) * | 2020-05-25 | 2023-01-01 | Novabiotics Ltd | Antiviral treatment |
WO2022040045A1 (en) * | 2020-08-18 | 2022-02-24 | New Amsterdam Sciences, Inc. | Sod mimetic and methods of using same for the treatment of covid-19 |
WO2023107996A1 (en) * | 2021-12-07 | 2023-06-15 | Cila Therapeutic Inc. | Anti-viral therapeutic agents and uses thereof |
WO2024009307A1 (en) * | 2022-07-06 | 2024-01-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Viroporins blockers/inhibitors as anti-flaviviruses agents |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3152180A (en) | 1960-08-25 | 1964-10-06 | Studiengesellschaft Kohle Mbh | Process for the production of nu-tert-alkyl amides and, if desired, nu-tert. alkyl amines |
US3352912A (en) | 1963-07-24 | 1967-11-14 | Du Pont | Adamantanes and tricyclo[4. 3. 1. 1 3.8] undecanes |
US3538160A (en) | 1965-03-24 | 1970-11-03 | Smithkline Corp | Pentacyclooctaneamines |
US3483254A (en) | 1967-01-03 | 1969-12-09 | Merck & Co Inc | 2-bornanemethylamines |
US3496228A (en) | 1967-02-16 | 1970-02-17 | Smithkline Corp | Aminotricyclononanes and the salts thereof |
US3534084A (en) | 1968-10-16 | 1970-10-13 | Squibb & Sons Inc | Adamantylamino-naphthyloxypropanols and related compounds |
US3592934A (en) | 1969-06-20 | 1971-07-13 | Du Pont | Pharmaceutical compositions and methods of controlling influenza a virus infection utilizing substituted adamantanes and tricyclo(4.3.1.13.8) undecanes |
IT1055560B (it) * | 1974-05-02 | 1982-01-11 | Istituto Chemioterapico | Derivati pirimidinici e relative composizioni per il trattamento di infezioni virali |
US5576351A (en) * | 1989-12-29 | 1996-11-19 | Mcgaw, Inc. | Use of arginine as an immunostimulator |
US5292773A (en) * | 1990-02-14 | 1994-03-08 | Hirsch Gerald P | Treating aids and HIV infection with methionine |
ES2027527A6 (es) * | 1990-12-17 | 1992-06-01 | Andromaco Lab | Procedimiento para la obtencion de polimeros dotados de actividad antiviral. |
DE4103177A1 (de) | 1991-02-02 | 1992-08-06 | Boehringer Mannheim Gmbh | Thiazolo-(2,3-a)isoindol-derivate und diese enthaltende arzneimittel |
US5314917A (en) * | 1991-03-22 | 1994-05-24 | E. B. Michaels Research Associates, Inc. | Method for inactivating enveloped viruses and sperm |
MX9205549A (es) | 1991-09-30 | 1993-05-01 | Jess G Thoene | Metodo para el tratamiento de vih. |
US5554655A (en) * | 1991-09-30 | 1996-09-10 | Jess G. Thoene | Method of treating HIV infection |
US5686436A (en) * | 1993-05-13 | 1997-11-11 | Hiv Diagnostics, Inc. | Multi-faceted method to repress reproduction of latent viruses in humans and animals |
EP0789565A4 (en) * | 1993-10-15 | 1999-03-24 | Jess G Thoene | PREVENTION OF HIV INFECTION |
US5725870A (en) * | 1993-10-15 | 1998-03-10 | Thoene; Jess G. | Methods, composites and articles for contraception |
US5714519A (en) | 1995-06-07 | 1998-02-03 | Ergo Science Incorporated | Method for regulating glucose metabolism |
US5684024A (en) | 1996-01-25 | 1997-11-04 | Viropharma Incorporated | Pyrazole dimers compositions and methods for treating influenza |
US5821243A (en) | 1996-07-22 | 1998-10-13 | Viropharma Incorporated | Compounds compositions and methods for treating influenza |
EP1067922A1 (en) * | 1998-03-30 | 2001-01-17 | The Endowment For Research In Human Biology, Inc. | Agents and methods for modulation of zinc transfer by metallothionein |
DE19817511A1 (de) * | 1998-04-20 | 1999-10-21 | Werner Slenczka | Antivirale Wirksamkeit der Pantothensäure, des Dexpanthenols und ihrer Derivate. Hemmwirkung auf die Virusreplikation umhüllter Viren durch Blockade des Fusionsvorgangs. |
US6063383A (en) * | 1999-01-28 | 2000-05-16 | Hsu; Wu-Ching | Pharmaceutical suppository composites for fever and influenza and method of producing the composites |
US6468522B1 (en) | 1999-07-22 | 2002-10-22 | University Of Medicine And Dentistry Of New Jersey | Controlled release of thioamide moiety-containing therapeutic agents |
US6521266B1 (en) | 1999-09-23 | 2003-02-18 | Morris A. Mann | Composition for growth hormone production and release, appetite suppression, and methods related thereto |
RU2175230C1 (ru) | 2001-01-23 | 2001-10-27 | Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" | Фармацевтическая композиция с противовирусной активностью и способ ее получения |
WO2002087593A1 (en) * | 2001-04-25 | 2002-11-07 | Cobalz Limited | A method for treating or preventing a functional vitamin b12 deficiency in an individual and to medical compositions for use in said method |
GB2377874B (en) * | 2001-07-23 | 2005-06-22 | Walcom Bio Chemicals Ind Ltd | Poultry feed and the use thereof |
AU2003249543A1 (en) * | 2002-07-11 | 2004-02-02 | Immune Network Ltd. | Sulphydryl compounds in combination with sulphone or sulphnamide conpounds for use in microbial inflammatory diseases |
US8017651B2 (en) * | 2002-11-22 | 2011-09-13 | Bionexus, Ltd. | Compositions and methods for the treatment of HIV-associated fat maldistribution and hyperlipidemia |
AU2003900064A0 (en) * | 2003-01-09 | 2003-01-23 | Penam Investments Pty. Ltd. | A method of treatment or prophylaxis of viral infection. |
GB2398497A (en) * | 2003-02-19 | 2004-08-25 | Walcom Animal Science | Composition for improving immunity of animals |
US20040191295A1 (en) * | 2003-03-28 | 2004-09-30 | Locniskar Mary Frances | Composition and method for viral inhibition |
DE10340845A1 (de) * | 2003-09-04 | 2005-03-31 | Flavin-Koenig, Dana F., Dr. | Pharmazeutisches Kombinationspräparat, enthaltend Glycyrrhizinsäure, Zink und eine Verbindung, die eine Thiolgruppe oder eine zu dieser metabolisierbare Gruppe enthält |
AR057623A1 (es) * | 2005-11-28 | 2007-12-05 | Omega Bio Pharma H K Ltd | Materiales y metodos para el tratamiento de las infecciones virales |
-
2006
- 2006-11-22 AR ARP060105117A patent/AR057623A1/es unknown
- 2006-11-24 TW TW095143633A patent/TWI401079B/zh not_active IP Right Cessation
- 2006-11-27 MY MYPI20064570A patent/MY141003A/en unknown
- 2006-11-28 AP AP2008004511A patent/AP2877A/xx active
- 2006-11-28 BR BRPI0619377-3A patent/BRPI0619377A2/pt not_active IP Right Cessation
- 2006-11-28 NZ NZ568464A patent/NZ568464A/en not_active IP Right Cessation
- 2006-11-28 ES ES06838553T patent/ES2392976T3/es active Active
- 2006-11-28 JP JP2008542483A patent/JP5138603B2/ja not_active Expired - Fee Related
- 2006-11-28 WO PCT/US2006/045652 patent/WO2007062272A1/en active Application Filing
- 2006-11-28 CN CN2010105707294A patent/CN102038667A/zh active Pending
- 2006-11-28 MX MX2008006851A patent/MX2008006851A/es active IP Right Grant
- 2006-11-28 US US11/605,551 patent/US8415398B2/en not_active Expired - Fee Related
- 2006-11-28 DK DK06838553.3T patent/DK1954258T3/da active
- 2006-11-28 KR KR1020087015869A patent/KR101440629B1/ko not_active IP Right Cessation
- 2006-11-28 PL PL06838553T patent/PL1954258T3/pl unknown
- 2006-11-28 EP EP06838553A patent/EP1954258B8/en not_active Not-in-force
- 2006-11-28 CA CA2631241A patent/CA2631241C/en not_active Expired - Fee Related
- 2006-11-28 PT PT06838553T patent/PT1954258E/pt unknown
- 2006-11-28 AU AU2006318355A patent/AU2006318355B2/en not_active Ceased
-
2008
- 2008-05-26 IL IL191705A patent/IL191705A/en not_active IP Right Cessation
-
2009
- 2009-04-03 HK HK09103170.7A patent/HK1123726A1/xx not_active IP Right Cessation
-
2013
- 2013-04-04 US US13/856,911 patent/US9283198B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
BRPI0619377A2 (pt) | 2011-09-27 |
IL191705A0 (en) | 2009-02-11 |
AU2006318355A1 (en) | 2007-05-31 |
US9283198B2 (en) | 2016-03-15 |
IL191705A (en) | 2013-11-28 |
AP2008004511A0 (en) | 2008-06-30 |
CA2631241C (en) | 2014-02-11 |
TWI401079B (zh) | 2013-07-11 |
CN102038667A (zh) | 2011-05-04 |
HK1123726A1 (en) | 2009-06-26 |
ES2392976T3 (es) | 2012-12-17 |
JP2009517395A (ja) | 2009-04-30 |
MY141003A (en) | 2010-02-12 |
DK1954258T3 (da) | 2012-10-15 |
US20130338113A1 (en) | 2013-12-19 |
US8415398B2 (en) | 2013-04-09 |
KR20080077658A (ko) | 2008-08-25 |
JP5138603B2 (ja) | 2013-02-06 |
WO2007062272A1 (en) | 2007-05-31 |
KR101440629B1 (ko) | 2014-09-15 |
PT1954258E (pt) | 2012-10-22 |
PL1954258T3 (pl) | 2013-01-31 |
EP1954258B1 (en) | 2012-09-05 |
MX2008006851A (es) | 2008-10-09 |
TW200733953A (en) | 2007-09-16 |
AP2877A (en) | 2014-03-31 |
NZ568464A (en) | 2010-09-30 |
AU2006318355B2 (en) | 2012-01-12 |
EP1954258A1 (en) | 2008-08-13 |
EP1954258B8 (en) | 2012-10-10 |
US20070135525A1 (en) | 2007-06-14 |
CA2631241A1 (en) | 2007-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR057623A1 (es) | Materiales y metodos para el tratamiento de las infecciones virales | |
EA201000556A1 (ru) | Спиропирролидины и их применение для борьбы с инфицированием посредством hcv (вирус гепатита с) и вич (вирус иммунодефицита человека) | |
ECSP17064986A (es) | Compuestos antivirales | |
CL2015000870A1 (es) | Análogos de 2' -cloro nucleósido para infección por vhc. | |
ECSP11011310A (es) | Análogos carba - nucleósido para tratamiento antiviral | |
CO6761348A2 (es) | Compuestos antivirales | |
ECSP10010609A (es) | Carba-nucleosidos analogos 1' - sustituidos para tratamiento antiviral | |
EA201490588A1 (ru) | Способы лечения вируса гепатита с | |
AR084237A1 (es) | Metodos para tratar virus de hepatitis c (hcv), composicion | |
ECSP14013315A (es) | Inhibidores de aplicación viral | |
CL2015001971A1 (es) | Compuestos tetracíclicos sustituidos con heterociclo y métodos de uso de los mismos para el tratamiento de enfermedades víricas. | |
EA201590197A1 (ru) | Соединения для лечения парамиксовирусных вирусных инфекций | |
UY32715A (es) | Combinaciones farmacéuticas útiles para el tratamiento del virus de la hepatitis c (vhc), usos y métodos relacionados | |
EA201491548A1 (ru) | 2'-замещенные карбануклеозидные аналоги для противовирусного лечения | |
ATE475660T1 (de) | Antivirale verbindungen | |
ECSP109889A (es) | Composiciones terapeuticas y usos de las mismas | |
UY32720A (es) | Combinaciones farmaceuticas utiles para el tratamiento del virus de la hepatitis c (vhc), usos y metodos relacionados | |
UY32721A (es) | Composiciones farmacéuticas útiles para tratar el virus de la hepatitis c (vhc), usos y métodos relacionados | |
EA201170605A1 (ru) | Циклоундекадепсипептидные соединения и применение указанных соединений в качестве лекарственного средства | |
SV2007002309A (es) | Compuestos 5-nitro-nucleosidos para tratar infecciones virales | |
EA201001748A1 (ru) | Соединения, используемые для лечения гепатита с | |
SV2005001919A (es) | Compuestos nucleosidos para el tratamiento de infecciones virales | |
WO2007076091A3 (en) | Treatment of viral infections using a tissue factor inhibitor | |
EA200602073A1 (ru) | Лечение или предупреждение респираторных вирусных инфекций с помощью иммуномодуляторов | |
CO2022014031A2 (es) | Compuestos para su uso en infecciones víricas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |